Skip to main content
FinSpry Logo
FinSpry
ARMP logo
ARMP
(NYSEAMERICAN)
Armata Pharmaceuticals, Inc.
$10.18-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Armata Pharmaceuticals, Inc. (ARMP) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Armata Pharmaceuticals, Inc. stock.

Analyst Consensus Rating

Investment consensus from 3 professional research analysts

Consensus Rating

Buy
Based on 3 unique analysts
Low Confidence2.0:1 Buy/Sell

Average Price Target

$15.00
↑ 47.35% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest ARMP Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Edmund Ingham
Forbes
SellInitiates Coverage
-
Joseph Pantginis
HC Wainwright
Strong BuyMaintains
$9.00 → $15.00
Debanjana Chatterjee
Jones Trading
Strong BuyInitiates
$15.00

Frequently Asked Questions

What is the analyst consensus rating for ARMP?

The analyst consensus rating for ARMP is "Buy" based on 3 analyst recommendations.

What is the average price target for ARMP?

The average 12-month price target for ARMP is $15.00, representing an upside of 47.3% from the current price of $10.18.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.